NCCAM Strategy Stresses Steps Toward Better Trials For Supplements
This article was originally published in The Tan Sheet
Executive Summary
The nutritional product industry expects benefits from the National Center for Complementary and Alternative Medicine draft strategic plan's emphasis on funding more preliminary research needed to launch informative clinical trials on supplement ingredients
You may also be interested in...
Setting RCT ‘Health’ Endpoints Suggested To Measure Supplement Efficacy
Dietary supplement industry researchers should move away from the medicine model in trials, the scientific director for KGK Synergize says. Researchers should consider new endpoints more appropriate for supplements than for drug ingredients.
Setting RCT ‘Health’ Endpoints Suggested To Measure Supplement Efficacy
Dietary supplement industry researchers should move away from the medicine model in trials, the scientific director for KGK Synergize says. Researchers should consider new endpoints more appropriate for supplements than for drug ingredients.
DHA Omega-3 Study Leaves Door Open For Role In Dementia Onset Prevention
Researchers conclude DHA fatty acid supplementation does not treat Alzheimer's disease, but they say the omega-3 substance may help prevent the onset of dementia.